These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29914943)

  • 1. Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis.
    Stott KE; Beardsley J; Kolamunnage-Dona R; Castelazo AS; Kibengo FM; Mai NTH; Tùng NLN; Cuc NTK; Day J; Hope W
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.
    Stott KE; Beardsley J; Whalley S; Kibengo FM; Mai NTH; Tùng NLN; Cuc NTK; Kolamunnage-Dona R; Hope W; Day J
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
    Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.
    Sudan A; Livermore J; Howard SJ; Al-Nakeeb Z; Sharp A; Goodwin J; Gregson L; Warn PA; Felton TW; Perfect JR; Harrison TS; Hope WW
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2793-800. PubMed ID: 23571544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
    Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
    Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
    Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
    Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
    Pastick KA; Nalintya E; Tugume L; Ssebambulidde K; Stephens N; Evans EE; Ndyetukira JF; Nuwagira E; Skipper C; Muzoora C; Meya DB; Rhein J; Boulware DR; Rajasingham R
    Med Mycol; 2020 Apr; 58(3):282-292. PubMed ID: 31689712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
    Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
    PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
    Smith KD; Achan B; Hullsiek KH; McDonald TR; Okagaki LH; Alhadab AA; Akampurira A; Rhein JR; Meya DB; Boulware DR; Nielsen K;
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7197-204. PubMed ID: 26324276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
    Ngan NTT; Thanh Hoang Le N; Vi Vi NN; Van NTT; Mai NTH; Van Anh D; Trieu PH; Lan NPH; Phu NH; Chau NVV; Lalloo DG; Hope W; Beardsley J; White NJ; Geskus R; Thwaites GE; Krysan D; Tai LTH; Kestelyn E; Binh TQ; Hung LQ; Tung NLN; Day JN
    Elife; 2021 Sep; 10():. PubMed ID: 34581270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
    Lestner J; McEntee L; Johnson A; Livermore J; Whalley S; Schwartz J; Perfect JR; Harrison T; Hope W
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
    Perfect JR; Cox GM; Dodge RK; Schell WA
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
    Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
    Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole and amphotericin B for cryptococcal meningitis.
    Clark AB; Lobo BL; Gelfand MS
    Ann Pharmacother; 1996 Dec; 30(12):1408-10. PubMed ID: 8968453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.